TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from China Touyun Tech Group ( (HK:1332) ) is now available.
Touyun Biotech Group Limited reported its annual results for the year ending December 31, 2024, showing a significant reduction in losses compared to the previous year. The company achieved a gross profit of HK$62.8 million, up from HK$56 million in 2023, despite a decrease in revenue from sales of goods and services. The improvement in financial performance is attributed to a fair value gain on financial assets and increased interest income from its money lending business, although the company still reported an overall loss of HK$88 million.
More about China Touyun Tech Group
Touyun Biotech Group Limited, incorporated in Bermuda, operates in the biotech industry with a focus on treasury investment, money lending, and sales of goods and services.
YTD Price Performance: -5.79%
Average Trading Volume: 126,582
Technical Sentiment Signal: Buy
Current Market Cap: HK$502.3M
For a thorough assessment of 1332 stock, go to TipRanks’ Stock Analysis page.